 Connection
Ihab Kamel to Image Enhancement
This is a "connection" page, showing publications Ihab Kamel has written about Image Enhancement.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
4.721 |
|
|
|
-
Fabrega-Foster KE, Agarwal S, Rastegar N, Haverstock D, Agris JM, Kamel IR. Efficacy and safety of gadobutrol-enhanced MRA of the renal arteries: Results from GRAMS (Gadobutrol-enhanced renal artery MRA study), a prospective, intraindividual multicenter phase 3 blinded study. J Magn Reson Imaging. 2018 02; 47(2):572-581.
Score: 0.497
-
Xu C, Sobhani F, Murano E, Corona-Villalobos C, Pozzessere C, Rastegar N, Kamel IR. Liver Malignancies Treated With Intra-Arterial Therapy: Assessment of Early Response as Quantified by Volumetric Enhancement Using Gadoxetate Disodium. J Comput Assist Tomogr. 2016 Mar-Apr; 40(2):206-11.
Score: 0.455
-
Bonekamp D, Bonekamp S, Ou HY, Torbenson MS, Corona-Villalobos CP, Mezey E, Kamel IR. Assessing liver fibrosis: comparison of arterial enhancement fraction and diffusion-weighted imaging. J Magn Reson Imaging. 2014 Nov; 40(5):1137-46.
Score: 0.389
-
Bonekamp S, Bonekamp D, Geschwind JF, Corona-Villalobos CP, Reyes DK, Pawlik TM, Kamel IR. Response stratification and survival analysis of hepatocellular carcinoma patients treated with intra-arterial therapy using MR imaging-based arterial enhancement fraction. J Magn Reson Imaging. 2014 Nov; 40(5):1103-11.
Score: 0.388
-
Ou HY, Bonekamp S, Bonekamp D, Corona-Villalobos CP, Torbenson MS, Geiger B, Kamel IR. MRI arterial enhancement fraction in hepatic fibrosis and cirrhosis. AJR Am J Roentgenol. 2013 Oct; 201(4):W596-602.
Score: 0.385
-
Gowdra Halappa V, Corona Villalobos CP, Bonekamp S, Gearhart SL, Efron J, Herman J, Kamel IR. Rectal imaging: part 1, High-resolution MRI of carcinoma of the rectum at 3 T. AJR Am J Roentgenol. 2012 Jul; 199(1):W35-42.
Score: 0.353
-
Bonekamp S, Jolepalem P, Lazo M, Gulsun MA, Kiraly AP, Kamel IR. Hepatocellular carcinoma: response to TACE assessed with semiautomated volumetric and functional analysis of diffusion-weighted and contrast-enhanced MR imaging data. Radiology. 2011 Sep; 260(3):752-61.
Score: 0.331
-
Vossen JA, Buijs M, Geschwind JF, Liapi E, Prieto Ventura V, Lee KH, Bluemke DA, Kamel IR. Diffusion-weighted and Gd-EOB-DTPA-contrast-enhanced magnetic resonance imaging for characterization of tumor necrosis in an animal model. J Comput Assist Tomogr. 2009 Jul-Aug; 33(4):626-30.
Score: 0.287
-
Najmi Varzaneh F, Pandey A, Aliyari Ghasabeh M, Shao N, Khoshpouri P, Pandey P, Zarghampour M, Fouladi D, Liddell R, Anders RA, Kamel IR. Prediction of post-TACE necrosis of hepatocellular carcinoma usingvolumetric enhancement on MRI and volumetric oil deposition on CT, with pathological correlation. Eur Radiol. 2018 Jul; 28(7):3032-3040.
Score: 0.130
-
Chu LC, Corona-Villalobos CP, Halushka MK, Zhang Y, Pozzessere C, Kamel IR, Pozios I, Van Der Geest RJ, Gai N, Abraham RM, Abraham TP, Bluemke DA, Zimmerman SL. Structural and Functional Correlates of Myocardial T1 Mapping in 321 Patients With Hypertrophic Cardiomyopathy. J Comput Assist Tomogr. 2017 Jul/Aug; 41(4):653-660.
Score: 0.125
-
Li H, Liang L, Li A, Hu Y, Hu D, Li Z, Kamel IR. Monoexponential, biexponential, and stretched exponential diffusion-weighted imaging models: Quantitative biomarkers for differentiating renal clear cell carcinoma and minimal fat angiomyolipoma. J Magn Reson Imaging. 2017 07; 46(1):240-247.
Score: 0.119
-
Chu LC, Pozzessere C, Corona-Villalobos CP, Castaños S, Rastegar N, Halappa V, Bonekamp S, Emurano E, Kamel IR. Evaluation of Hepatocellular Carcinoma Tumor Response After Transcatheter Arterial Chemoembolization Using Gadobenate Dimeglumine-Enhanced Liver Magnetic Resonance. J Comput Assist Tomogr. 2016 Nov/Dec; 40(6):856-862.
Score: 0.119
-
Qu J, Han S, Zhang H, Liu H, Wang Z, Kamel IR, Berthold K, Dominik NM, Zhang S, Dong Y, Jiang L, Liu C, Li H. Improved Detection of Recurrent Hepatocellular Carcinomas in Arterial Phase With CAIPIRINHA-Dixon-TWIST-Volumetric Interpolated Breath-Hold Examination. Invest Radiol. 2016 10; 51(10):602-8.
Score: 0.119
-
Pozzessere C, Porter KK, Kamel IR. Surveillance liver MRI for monitoring patients with known or suspected chronic liver disease. Clin Radiol. 2017 Jan; 72(1):93.e7-93.e13.
Score: 0.118
-
Pozzessere C, Castaños Gutiérrez SL, Corona-Villalobos CP, Righi L, Xu C, Lennon AM, Wolfgang CL, Hruban RH, Goggins M, Canto MI, Kamel IR. Diffusion-Weighted Magnetic Resonance Imaging in Distinguishing Between Mucin-Producing and Serous Pancreatic Cysts. J Comput Assist Tomogr. 2016 Jul-Aug; 40(4):505-12.
Score: 0.116
-
Corona-Villalobos CP, Halappa VG, Bonekamp S, Eng J, Reyes D, Cosgrove D, Rastegar N, Pan L, Pawlik TM, Kamel IR. Functional magnetic resonance imaging response of targeted tumor burden and its impact on survival in patients with hepatocellular carcinoma. Invest Radiol. 2015 Apr; 50(4):283-9.
Score: 0.107
-
Baker ME, Nelson RC, Rosen MP, Blake MA, Cash BD, Hindman NM, Kamel IR, Kaur H, Piorkowski RJ, Qayyum A, Yarmish GM. ACR Appropriateness Criteria® acute pancreatitis. Ultrasound Q. 2014 Dec; 30(4):267-73.
Score: 0.104
-
Corona-Villalobos CP, Zhang Y, Zhang WD, Kamel IR. Magnetic resonance imaging of the liver after loco-regional and systemic therapy. Magn Reson Imaging Clin N Am. 2014 Aug; 22(3):353-72.
Score: 0.102
-
Corona-Villalobos CP, Kamel IR. Functional volumetric MRI in assessing treatment response to intra-arterial therapy of primary and secondary liver tumors. J Comput Assist Tomogr. 2014 Jul-Aug; 38(4):513-7.
Score: 0.101
-
Bonekamp D, Bonekamp S, Halappa VG, Geschwind JF, Eng J, Corona-Villalobos CP, Pawlik TM, Kamel IR. Interobserver agreement of semi-automated and manual measurements of functional MRI metrics of treatment response in hepatocellular carcinoma. Eur J Radiol. 2014 Mar; 83(3):487-96.
Score: 0.097
-
Liapi E, Geschwind JF, Vossen JA, Buijs M, Georgiades CS, Bluemke DA, Kamel IR. Functional MRI evaluation of tumor response in patients with neuroendocrine hepatic metastasis treated with transcatheter arterial chemoembolization. AJR Am J Roentgenol. 2008 Jan; 190(1):67-73.
Score: 0.065
-
Buijs M, Kamel IR, Vossen JA, Georgiades CS, Hong K, Geschwind JF. Assessment of metastatic breast cancer response to chemoembolization with contrast agent enhanced and diffusion-weighted MR imaging. J Vasc Interv Radiol. 2007 Aug; 18(8):957-63.
Score: 0.063
-
Vogel-Claussen J, Rochitte CE, Wu KC, Kamel IR, Foo TK, Lima JA, Bluemke DA. Delayed enhancement MR imaging: utility in myocardial assessment. Radiographics. 2006 May-Jun; 26(3):795-810.
Score: 0.058
-
Chu LC, Porter KK, Corona-Villalobos CP, Gülsün MA, Shea SM, Markl M, Abraham TP, Bluemke DA, Kamel IR, Zimmerman SL. Evaluation of Left Ventricular Outflow Tract Obstruction With Four-Dimensional Phase Contrast Magnetic Resonance Imaging in Patients with Hypertrophic Cardiomyopathy-A Pilot Study. J Comput Assist Tomogr. 2016 Nov-Dec; 40(6):937-940.
Score: 0.030
-
Rastegar N, Te Riele AS, James CA, Bhonsale A, Murray B, Tichnell C, Calkins H, Tandri H, Bluemke DA, Kamel IR, Zimmerman SL. Fibrofatty Changes: Incidence at Cardiac MR Imaging in Patients with Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy. Radiology. 2016 08; 280(2):405-12.
Score: 0.029
-
Malayeri AA, El Khouli RH, Zaheer A, Jacobs MA, Corona-Villalobos CP, Kamel IR, Macura KJ. Principles and applications of diffusion-weighted imaging in cancer detection, staging, and treatment follow-up. Radiographics. 2011 Oct; 31(6):1773-91.
Score: 0.021
-
Liapi E, Kamel IR, Bluemke DA, Jacobs MA, Kim HS. Assessment of response of uterine fibroids and myometrium to embolization using diffusion-weighted echoplanar MR imaging. J Comput Assist Tomogr. 2005 Jan-Feb; 29(1):83-6.
Score: 0.013
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|